Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

B. Benson, Al; P. Venook, Alan; Adam, Mohamed; Chang, George; Chen, Yi-Jen; K. Ciombor, Kristen; A. Cohen, Stacey; S. Cooper, Harry; Deming, Dustin; Garrido-Laguna, Ignacio; L. Grem, Jean; Haste, Paul; Randolph Hecht, J.; Hoffe, Sarah; Hunt, Steven; Hussan, Hisham; L. Johung, Kimberly; Joseph, Nora; Kirilcuk, Natalie; Krishnamurthi, Smitha; Malla, Midhun; K. Maratt, Jennifer; A. Messersmith, Wells; Meyerhardt, Jeffrey; D. Miller, Eric; F. Mulcahy, Mary; Nurkin, Steven; J. Overman, Michael; Parikh, Aparna; Patel, Hitendra; Pedersen, Katrina; Saltz, Leonard; Schneider, Charles; Shibata, David; Shogan, Benjamin; M. Skibber, John; T. Sofocleous, Constantinos; Tavakkoli, Anna; G. Willett, Christopher; Wu, Christina; A. Gurski, Lisa; Snedeker, Jenna; Jones, Frankie

doi:10.6004/jnccn.2024.0029

Public

Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

Shared by NobleBlocks on Jun 1, 2024 • 12:00 AM UTC

Authors:

Al B. Benson

Alan P. Venook

Mohamed Adam

Abstract

Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer and the second leading cause of cancer death in the United States. Management of disseminated metastatic CRC involves various active drugs, either in combination or as single agents. The choice of therapy is based on consideratio...

Discussions